Synergy evaluation of cefepime/enmetazobactam in combination with novel β-lactam/β-lactamase inhibitor combinations (βL/βLICs) against <i>Klebsiella pneumoniae</i> carrying different <i>bla</i><sub>KPC</sub> variants